[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100232625":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":29,"locations":37,"responsibleParty":160,"collaborators":163,"id":171,"slug":172,"hasResults":173,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":177,"eligibilityCriteria":178,"healthyVolunteers":173,"sex":179,"minAge":7,"maxAge":7,"enrollmentInfo":180,"targetDuration":7,"studyType":183,"phases":7,"briefSummary":184,"conditions":185,"keywords":187,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":205,"lastUpdatePostDateStruct":206,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":214},{"fullName":5,"class":6},"Lund University","OTHER",null,[9,12,15,18,21,23,25,27],{"name":10,"affiliation":5,"role":11},"Åke Borg, PhD","STUDY_DIRECTOR",{"name":13,"affiliation":5,"role":14},"Cecilia Hegardt, PhD","STUDY_CHAIR",{"name":16,"affiliation":5,"role":17},"Christer Larsson, PhD","PRINCIPAL_INVESTIGATOR",{"name":19,"affiliation":20,"role":17},"Niklas Loman, MD, PhD","Skane University Hospital",{"name":22,"affiliation":5,"role":17},"Johan Vallon-Christersson, PhD",{"name":24,"affiliation":20,"role":17},"Anna Ehinger, MD, PhD",{"name":26,"affiliation":20,"role":17},"Lisa Rydén, MD, PhD",{"name":28,"affiliation":5,"role":17},"Lao H Saal, MD, PhD",[30,34],{"name":10,"role":31,"phone":32,"phoneExt":7,"email":33},"CONTACT","+46-46-2752552","ake.borg@med.lu.se",{"name":35,"role":31,"phone":7,"phoneExt":7,"email":36},"Lao Saal, MD, PhD","lao.saal@med.lu.se",[38,51,65,79,92,105,119,132,146],{"facility":39,"status":40,"city":41,"state":7,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":7},"Hallands Hospital Halmstad","SUSPENDED","Halmstad","30233","Sweden","SE",{"type":46,"coordinates":47},"Point",[48,49],12.85676,56.67446,{"lat":49,"lon":48},{"facility":52,"status":53,"city":54,"state":7,"zip":55,"country":43,"countryCode":44,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Helsingborg Hospital","RECRUITING","Helsingborg","25187",{"type":46,"coordinates":57},[58,59],12.69437,56.04673,{"lat":59,"lon":58},[62],{"name":63,"role":31,"phone":7,"phoneExt":7,"email":64},"Anna-Karin Falck, MD","anna-karin.falck@skane.se",{"facility":66,"status":53,"city":67,"state":7,"zip":68,"country":43,"countryCode":44,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Kirurgiska kliniken","Jönköping","55185",{"type":46,"coordinates":70},[71,72],14.15618,57.78145,{"lat":72,"lon":71},[75],{"name":76,"role":31,"phone":77,"phoneExt":7,"email":78},"Bengt Asking, MD","+46-36-321353","bengt.asking@rjl.se",{"facility":80,"status":53,"city":81,"state":7,"zip":82,"country":43,"countryCode":44,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Blekinge County Hospital","Karlskrona","37185",{"type":46,"coordinates":84},[85,86],15.58661,56.16156,{"lat":86,"lon":85},[89],{"name":90,"role":31,"phone":7,"phoneExt":7,"email":91},"Monika Sjövall, MD","monika.sjovall@ltblekinge.se",{"facility":93,"status":53,"city":94,"state":7,"zip":95,"country":43,"countryCode":44,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Central Hospital Kristianstad","Kristianstad","29185",{"type":46,"coordinates":97},[98,99],14.15242,56.03129,{"lat":99,"lon":98},[102],{"name":103,"role":31,"phone":7,"phoneExt":7,"email":104},"Tor Svensjö, MD, PhD","tor.svensjo@skane.se",{"facility":106,"status":53,"city":107,"state":7,"zip":108,"country":43,"countryCode":44,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Skåne University Hospital","Lund","22185",{"type":46,"coordinates":110},[111,112],13.19321,55.70584,{"lat":112,"lon":111},[115],{"name":116,"role":31,"phone":117,"phoneExt":7,"email":118},"Lisa Rydén, MD PhD","+46-46-176241","lisa.ryden@med.lu.se",{"facility":106,"status":53,"city":120,"state":7,"zip":121,"country":43,"countryCode":44,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"Malmö","20502",{"type":46,"coordinates":123},[124,125],13.00073,55.60587,{"lat":125,"lon":124},[128],{"name":129,"role":31,"phone":130,"phoneExt":7,"email":131},"Martin Rehn, MD, PhD","+46-40-331892","martin.rehn@skane.se",{"facility":133,"status":53,"city":134,"state":7,"zip":135,"country":43,"countryCode":44,"cosmosGeoPoint":136,"geoPoint":140,"contacts":141},"Uppsala University Hospital","Uppsala","75185",{"type":46,"coordinates":137},[138,139],17.63889,59.85882,{"lat":139,"lon":138},[142],{"name":143,"role":31,"phone":144,"phoneExt":7,"email":145},"Tobias Sjöblom, PhD","+46-18-4715036","tobias.sjoblom@igp.uu.se",{"facility":147,"status":53,"city":148,"state":7,"zip":149,"country":43,"countryCode":44,"cosmosGeoPoint":150,"geoPoint":154,"contacts":155},"Central Hospital Växjö","Vaxjo","35234",{"type":46,"coordinates":151},[152,153],14.80906,56.87767,{"lat":153,"lon":152},[156],{"name":157,"role":31,"phone":158,"phoneExt":7,"email":159},"Per Weber, MD","+46-470-588052","per.weber@ltkronoberg.se",{"type":17,"investigatorFullName":161,"investigatorTitle":162,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Åke Borg","Professor",[164,167,169],{"name":165,"class":166},"South Sweden Breast Cancer Group","UNKNOWN",{"name":168,"class":166},"Mrs. Berta Kamprad Foundation",{"name":170,"class":166},"U-CAN","100232625","sweden-cancerome-analysis-network---breast--genomic-profiling-of-breast-cancer-100232625",false,"NCT02306096","Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer","SCAN-B: The Sweden Cancerome Analysis Network - Breast Initiative","SCAN-B","Inclusion Criteria:\n\n* suspicion or confirmed diagnosis of primary breast cancer\n* signed informed consent\n\nExclusion Criteria:\n\n* lack of signed informed consent","ALL",{"count":181,"type":182},20000,"ESTIMATED","OBSERVATIONAL","This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.",[186],"Breast Neoplasms",[188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204],"prognostic and predictive biomarkers","RNA-sequencing","pathological complete response","minimal residual disease","molecular subtype","gene expression profiling","mutation screening","BRCA","translational research","genomics","transcriptomics","proteomics","metabolomics","liquid biopsy","circulating tumor cells","circulating tumor DNA","RNA-seq","2024-02-07",{"date":207,"type":208},"2024-02-09","ACTUAL",{"date":210,"type":7},"2010-08",{"date":212,"type":182},"2031-08",{"name":5,"class":6},9]